( Posted by Jennifer Landry)Acorda Therapeutics, the company that developed and is now marketing AMPYRA (dalfampridine) in the U.S., is hosting a webcast for MS bloggers on Wednesday, March 17 and our own Jennifer Landry has been invited to attend. Acorda’s senior leadership team, including their CEO Ron Cohen (above), are providing an overview of AMPYRA, including the clinical trial data and information on pricing and insurance. Most importantly, they are also taking questions from the attendees.
MS News Channel will be posting updates following the webcast, so stay tuned.
MS News Channel will be posting updates following the webcast, so stay tuned.
